Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
36,962,136
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
14,612,435
-
Shares change
-
+3,638,700
-
Total reported value, excl. options
-
$309,637,635
-
Value change
-
+$77,103,451
-
Number of buys
-
27
-
Number of sells
-
-6
-
Price
-
$21.19
Significant Holders of Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) as of Q1 2023
47 filings reported holding IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share as of Q1 2023.
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,612,435 shares
of 36,962,136 outstanding shares and own 40% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (3,461,784 shares), Novo Holdings A/S (2,340,772 shares), ORBIMED ADVISORS LLC (2,269,637 shares), Bain Capital Life Sciences Investors, LLC (1,990,914 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (826,936 shares), 5AM Venture Management, LLC (588,442 shares), Logos Global Management LP (525,000 shares), VANGUARD GROUP INC (322,869 shares), Rock Springs Capital Management LP (313,468 shares), and Foresite Capital Management V, LLC (243,513 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.